000 | 01571 a2200457 4500 | ||
---|---|---|---|
005 | 20250516031204.0 | ||
264 | 0 | _c20110812 | |
008 | 201108s 0 0 eng d | ||
022 | _a1436-2813 | ||
024 | 7 |
_a10.1007/s00595-009-4310-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMishra, Anjali | |
245 | 0 | 0 |
_aGlutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients. _h[electronic resource] |
260 |
_bSurgery today _cApr 2011 |
||
300 |
_a471-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aBreast Neoplasms, Male _xdrug therapy |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aGlutathione Transferase _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoadjuvant Therapy |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aChandra, Richa | |
700 | 1 | _aMehrotra, Prateek Kumar | |
700 | 1 | _aBajpai, Prachi | |
700 | 1 | _aAgrawal, Deepa | |
773 | 0 |
_tSurgery today _gvol. 41 _gno. 4 _gp. 471-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00595-009-4310-4 _zAvailable from publisher's website |
999 |
_c20701374 _d20701374 |